There’s a new multibillion-dollar medtech company in town. Right on schedule, PerkinElmer has completed the split it announced last August, selling off its applied science, food and enterprise ...

With the sell-off of its applied science, food and enterprise services businesses now complete, PerkinElmer is charting a new path with its remaining diagnostics and life sciences divisions. The first ...

On Tuesday, May 16, the name PerkinElmer and its PKI symbol disappeared from the stock market. In its place is a piece of the old company, branded as Revvity Inc. (NYSE:RVTY). PerkinElmer was formed ...

(Reuters) -PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...

PerkinElmer is acquiring Covaris, which manufactures applications and solutions for life science companies, as part of an effort to expand its life sciences portfolio. The biotech announced Monday ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Senior Vice President and Chief Financial Officer ...

SACRAMENTO (CBS13) — Following a CBS13 investigation into the state's COVID testing lab and its $1.7 billion contract with PerkinElmer, the company is now effectively suing a whistleblower who spoke ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) today announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science ...

Waltham-based PerkinElmer agreed to sell its Applied, Food, and Enterprise Services businesses to investment firm New Mountain Capital for up to $2.45 billion. The company announced the deal Monday ...